Tag: biosimilars

Authorized biologic alternatives, or biosimilars, are highly similar versions of complex biologic drugs that offer major cost savings without compromising safety. Unlike generics, they’re not exact copies-but they work just as well.

Lot-to-lot variability is a natural part of biologics and biosimilars due to their complex, cell-based manufacturing. Learn how regulators ensure safety, why biosimilars aren't generics, and what this means for patients and labs.